接受腹主动脉瘤监测的患者面临的心血管事件或恶性肿瘤威胁大于其腹主动脉瘤本身:一家三级血管中心19年腹主动脉瘤监测结局
结果显示32%死亡、23.8%手术,死亡主要归因于心血管事件(34.9%)和恶性肿瘤(27.3%)。作者认为应将AAA监测重点转向心血管、恶性肿瘤和呼吸系统疾病风险。
要点
- AAA监测患者中死亡(32%)比手术(23.8%)更常见。
- 已知死因中34.9%为心血管事件、27.3%为恶性肿瘤(主要为肺癌)。
- 作者认为应将AAA监测重点转向心血管、恶性肿瘤和呼吸系统疾病风险。
核心结论
- 基于该数据,AAA监测患者死亡(主要归因于心血管事件)比手术修复更可能发生,且与进入监测时年龄增加、初始AAA直径增大和女性性别相关。
- 监测中位时间超过三年半,为影响后续健康结局提供了足够时间,因此作者认为有必要将AAA监测重点转向处理心血管、恶性肿瘤和呼吸系统疾病风险。
研究设计与样本
- 回顾性分析前瞻性收集的数据库,纳入2000年9月至2019年6月在曼彻斯特大学NHS信托基金会Wythenshawe医院进入AAA监测的所有患者。
- 采用多变量分析确定进入监测时初始AAA大小、年龄和性别的影响。
主要发现
- 32%的患者死亡,23.8%接受手术,13.3%因合并症加重/严重而出院,3.1%被转院,27.7%仍在监测中。
- 手术时间较长与进入监测时年龄增加(OR 0.95,95%CI 0.94-0.96,P < 0.001)和初始AAA直径较小(OR 4.26,95%CI 3.80-4.78,P < 0.001)显著相关,与女性性别无关。
- 生存受损与年龄增加(OR 1.06,95%CI 1.05-1.07,P < 0.001)、初始AAA大小(OR 1.56,95%CI 1.39-1.74,P < 0.001)和女性性别(OR 1.40,95%CI 1.18-1.67,P < 0.001)相关。
- 在所有15年中,每年死亡发生率均高于手术修复。
- 在已知死因的死亡病例中(n=401),34.9%(n=108)死于心血管事件,27.3%(n=109)死于恶性肿瘤(主要为肺癌),19.3%死于呼吸系统疾病。
临床怎么用
- 作者认为有必要将AAA监测项目的重点转向处理心血管、恶性肿瘤和呼吸系统疾病风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To analyse 19 years' worth of data from a Major UK Vascular Centre to determine the outcome of patients after they enter abdominal aortic aneurysm (AAA) surveillance (surgery, death, discharge or transfer), this may inform interventions to improve these outcomes in the AAA surveillance population. METHODS: This was a retrospective analysis of a prospectively collected database of outcomes of every patient entered on AAA surveillance at Manchester University NHS Foundation Trust - Wythenshawe Hospital between September 2000 and June 2019. Analyses included what proportion suffered death, discharge, transfer or surgery whilst on surveillance. Multi-variate analysis was used to determine the effect of initial AAA size, age when entering surveillance and gender. Boxplots were produced in those who had already reached an outcome to determine historic median times. Causes of death/discharge were also analysed. RESULTS: One thousand nine hundred fifty-one patients were identified from the databased after data cleaning and were included in the final analysis. Thirty-two percent of patients had died, 23.8% had surgery, 13.3% were discharged due to worsening/severe comorbidity, 3.1% had been transferred and 27.7% were still active in surveillance. A longer time to surgery was significantly associated with increasing age on entering surveillance OR (95% CI) 0.95 (0.94-0.96) (P < 0.001), smaller initial AAA size 4.26 (3.80-4.78) (P < 0.001) but not female gender. Impaired survival was associated with increasing age 1.06 (1.05-1.07) (P < 0.001), initial AAA size, 1.56 (1.39-1.74) (P < 0.001) and female gender 1.40 (1.18-1.67) (P < 0.001). Overall, death occurred more frequently than operative repair every year over all 15 years. Out of the deaths where cause was known (n = 401), 34.9% (n = 108) were due to cardiovascular events, 27.3% (n = 109) due to malignancy (primarily lung), and 19.3% due to respiratory disease. CONCLUSIONS: Based on this data, death, primarily due to cardiovascular events, is a more likely outcome than operative repair in patients on AAA surveillance and is associated with increasing age, increasing AAA size and female gender. A median time on surveillance of over three and a half years provides sufficient time to affect subsequent health outcomes in this population and therefore a shift of focus of AAA surveillance programmes to address cardiovascular, malignancy and respiratory disease risk is warranted.
引用
- Haque A, McCollum C. Patients on AAA Surveillance are at Greater Threat of Cardiovascular Events or Malignancy than their AAA: Outcomes of AAA Surveillance over 19 years at a Tertiary Vascular Centre. Ann Vasc Surg. 2021. PMID: 34933105. doi:10.1016/j.avsg.2021.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。